News • Adaptable for screening
An optical methodology for rapid detection of COVID-19
The tool has made it possible to detect SARS-CoV-2 in exudate from symptomatic patients with a sensitivity of 100% and a specificity of 87.5%
Coronavirus
News • Decrease in wellbeing
Covid-19 pandemic has devastating effect on mental health, study shows
The Covid pandemic might be responsible for a “substantial decrease” in mental wellbeing in the UK, according to new research from the University of East Anglia and University of York.
News • Coronavirus long term effects
Vaccination protects against long Covid, study shows
A new UK review shows that people who have had one or more doses of a coronavirus vaccine are less likely to develop long Covid than those who remain unvaccinated.
News • Public transport
Down the tube: Is the Underground 'Covid safe'?
Is the Underground a safe means of transport in times of Covid-19? A computer simulation, developed at the University of Leeds, has calculated the infection risk.
News • Alternative to injection
Inhaled vaccine delivers broad protection against SARS-CoV-2
Scientists have confirmed that an inhaled form of COVID vaccine can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern.
News • COVID and E. coli
Futuristic coating for fabrics kills viruses
Researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 per cent.
News • Machine learning
Using Raman spectroscopy and AI for SARS-CoV-2 detection
Researchers have developed a noninvasive and reagent-free technique for the efficient detection of COVID-19.
News • Viral subtypes
Coronavirus evolution: 'Even Omicron has three variants'
Professor Richard Neher from the Biozentrum of the University of Basel is using his Nextstrain platform to investigate which variants of the SARS-CoV-2 virus are currently circulating worldwide.
News • New insights into antibody response
How the immune system reacts to coronavirus variants
Researchers from Charité – Universitätsmedizin Berlin and Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) present new findings on the immune response against SARS-CoV-2.
News • Coronavirus research
Why the Omicron variant causes less severe disease
A new study shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defence mechanism against viruses, the so-called 'interferon response'.
News • Sensitivity and response detection
How long do tests detect SARS-CoV-2 antibodies? New insights
How long can Covid-19 antigen tests reliably tell the antibody status? Researchers at the Paul-Ehrlich-Institut identified several factors that affect the detection duration.
News • Wearable
Air sampler assesses exposure to SARS-CoV-2
A passive air sampler clip can help assess personal exposure to SARS-CoV-2, which could be especially helpful for workers in high-risk settings.
News • Potential game-changer
Telling Covid-19 apart from influenza
Researchers have developed a diagnostic for Sars-CoV-2 that is capable of differentiating between Covid-19 and the garden-variety bug with fast turnaround.
News • Widespread effects
Tougher childbirth in pandemic Europe
The COVID-19 pandemic has led to deficiencies and large inequalities in the care of mothers and newborns in Europe.
Article • A potentially devastating impact
Covid-19 alters antibiotic use
The long-term impact of the coronavirus pandemic on antimicrobial resistance remains difficult to predict. Infectious diseases consultant Professor Alison Holmes reflects on Covid-19's effect on antibiotic use in hospitals and beyond.
News • Research
Quantum sensor to detect SARS-CoV-2 faster
Scientists at have designed a quantum sensor to detect SARS-CoV-2 faster, cheaper, and more accurate than the current gold-standard technique, PCR.
News • Tissue scarring
How a Covid-19 infection can damage the kidneys
The Coronavirus SARS-CoV-2 infects the kidneys and contributes to tissue scarring, as shown by researchers from Germany and the Netherlands.
News • New study
Antibodies can neutralize omicron
An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants.
News • Revealed via new x-ray technique
Covid-19 can cause vascular damage to the heart
Using a new x-ray imaging approach, an interdisciplinary research team has detected significant changes in the heart muscle tissue of people who died from Covid-19.
News • Coronavirus research
Why Omicron may be more evasive, but less severe
The Omicron variant of SARS-CoV-2 may be significantly better at evading vaccine-induced antibodies – but preliminary evidence suggests it is less likely to cause severe illness in the lungs.
News • UV-C barrier against aerosols
An 'invisible wall' to keep out SARS-CoV-2
An invisible protective wall of UV-C light developed by researchers in Munich could reliably curb the spread of viruses and other pathogens in rooms while allowing total freedom of movement.
News • Machine learning
Covid-19 diagnosis with improved accuracy, preserved privacy
Researchers in the UK and China have developed an AI model that can diagnose Covid-19 as well as a panel of professional radiologists, while preserving the privacy of patient data.
Article • Assessing infection severity
CT score predicts Covid-19 death risk
Radiologists in Paris have developed a standardised simple visual lung damage CT severity score for Covid-19 patients who do not have symptoms of severe acute respiratory syndrome (SARS) at the time of initial treatment.
News • Life-saving treatment
First double-lung transplant after Covid-19 performed in Portugal
Doctors in Lisbon report on the case of a 61-year-old man who received a double lung transplant after his lungs were irreparably damaged by Covid-19.
Article • Pandemic management
Lessons learned from Covid-19 by a large hospital radiology department
When the coronavirus first struck in the US, hospitals in New York City were the first to feel the impact. Radiologists Professor Judy Yee, M.D., and Mark C. Liszewski, M.D., describe the lessons learned and talk about their firsthand experiences.
